The pharmacological and biochemical mecha nisms of contractile responses to the protein kinase C (PKC) activator phorbol-12, 13-diacetate (PDA) were in vestigated in canine basilar arteries, In the normal me dium, PDA elicited a strong, dose-related, and slow developing sustained contraction, Among the constric tors examined, including serotonin, prostaglandin F 2 a' and endothelin, only PDA yielded contractions in a Ca 2 + -free medium, In both media, the PDA-induced con tractions were virtually inhibited by either staurosporine, H-7, or quinacrine, while neither neurotransmitter block ades nor R24571 (calmidazolium) exerted significant ef fects, In addition, it was shown that 8-bromocyclic GMP, ------.--�
The contraction of smooth muscle in response to various agonists is usually said to be composed of two phases: a fast "phasic" component followed by a slower, more sustained "tonic" component, With regard to the cellular mechanisms at work, the scheme that an initial precipitous rise in the calcium ion concentration in the cytosol leads to the phos phorylation of the light chain of myosin (MLC) through the calmodulin (CaM)-dependent activa tion of myosin light chain kinase (MLCK) (Bolton, 1979; van Breemen et aL, 1979; Adelstein et aL, 1980; Murphy et aL, 1983) has gained a large accep-but not 8-bromocyclic AMP, markedly curtailed the PDA-induced contractions, Biochemical analysis, fur thermore, showed that PDA induced increased phosphor ylations of 27-and 96-kDa and proteins other than the myosin light chain (MLC) 20-kDa protein, Thus, the present results open up a novel mechanism of sustained cerebral artery contractions, where PKC activation rather than Ca 2 + Icalmodulin/MLC system plays a key role that is regulated both by phospholipase A 2 and by cyclic GMP, Key Words: Canine basilar artery-Con tractile protein-Contraction-Cyclic nucleotides-Phor bol 12,l3-diacetate-Protein kinase C.
tance. It has turned out, however, that this concept cannot thoroughly explain the cellular mechanisms of contractile response since the agonist-induced rises in intracellular calcium ion concentration as well as the amount of phosphorylated MLC are transient, whereas the tension is maintained even after MLC phosphorylation has ceased (Chatterjee and Pritchard et aL, 1986) .
To explain the above discrepancy, Aksoy et aL (1983) have proposed that MLC phosphorylation leads to the formation of cycling cross-bridges, which then become latch bridges (Rembold and Murphy, 1986; Summerville and Hartshorne, 1986) , In line with this notion, Rasmussen et aL (1987) have put forward a novel hypothesis that the main tenance of sustained contraction depends mainly on the phosphorylation of cytosolic contractile pro teins by protein kinase C (PKC) on the basis of the following findings. First, the perfusion of rabbit ear arteries with 12-0-tetradecanoylphorbol 13-acetate, a PKC activator, leads to slowly developing, sus tained, calcium-dependent contraction (Rasmussen et aI., 1984) , Other phorbol esters such as 12-deoxyphorbol 13-isobutylate (DPB) and phorbol 12,13-dibutylate also initiate sustained contraction in various types of smooth muscles (Danthuluri and Deth, 1984; Baraban et aI., 1985; Forder et aI., 1985; Gleason and Flaim, 1986; Khalil and Van Breemen, 1988) . Second, smooth muscle is com monly rich in contractile proteins such as cal desmon, which is known to be a PKC substrate (Pritchard et aI., 1986) . Third, significant incre ments of 1, 2-diacylglycerol (DAG), an endogenous PKC activator, were observed following agonist induced sustained contraction of smooth muscle (Griendling et aI., 1986; Takuwa et aI., 1986) . These, together with other pieces of evidence, have led Rasmussen et al. (1987) to propose that there are at least two pathways by which agonists elicit con traction: a Ca 2 + ICaM pathway, which initiates the response, and a PKC pathway, which, along with the Ca 2 + ICaM pathway, sustains contraction. This notion supports the intriguing findings that (a) smooth muscle in general is rich in PKC (Yu, 1981) and (b) a certain type of agonist activates phospho lipase C (PLC), leading to the simultaneous forma tion of inositol 1 ,4,5-trisphosphate and DAG (Nish izuka, 1984) . The former substance stimulates the release of Ca 2 + from the intracellular store, while the latter stabilizes the membrane-bound form of PKC, thereby markedly enhancing its affinity to Ca 2 + and allowing it to become fully active (Nish izuka, 1984) . The precise role of the above described novel mechanism in the manifestation of cerebral artery contraction, however, has remained largely unsettled. Therefore, we undertook the present study using canine basilar arteries. Phorbol 12, 13-diacetate (PDA) was used throughout this ex periment as an activator of PKC (Malenka et aI., 1986) .
The present data provide direct evidence that PDA-induced canine basilar artery constriction is mediated exclusively by the activation of PKC, which is totally independent of the MLC phos phorylation via the Ca 2 + ICaM/MLCK system. Fur thermore, this study disclosed that cyclic GMP and phospholipase A 2 (PLA 2 ) play critical regulatory roles in the manifestation of PDA-induced contrac tion, whereas cyclic AMP does not.
METHODS

Measurement of contractile responses of canine basilar arteries
Contractile activities of canine basilar arteries were ex amined isometrically according to the method previously reported by us (Koide et aI., 1982) . Beagles of either sex were anesthetized with intravenous administration of so dium pentobarbital (30 mg/kg) and were killed by rapid exsanguination. The basilar artery was dissected out un-J Cereb Blood Flow Me/ab. Vol. 11, No. I, 1991 der magnification and was sectioned at 2-to 3-mm inter vals. A segment was mounted in a chamber (which was maintained at 37 ± 1°C) containing 5 ml of a buffer solu tion (120 mM NaCl, 4.5 mM KCl, 2.5 mM CaCI2, 1.0 mM MgCI2, 27.0 mM NaHC0 3 , 1.0 mM KH2P04, 0.01 mM disodium ethylenediaminetetraacetate, and 10.0 mM glu cose) bubbled with 95% O2 plus 5% CO2 gas (pH 7.4 ± 0.1). The segment was initially stretched at a tension of 400 mg for I h with a force-displacement transducer (SB IT; Nihon Kohden, Tokyo, Japan) during which time the buffer solution was changed several times. Experiments were started after the segment was stretched at a final tension of 3 g inasmuch as preliminary studies showed that this tension provided the optimum length. The total volume of agents never exceeded 250 f.Ll or 5% of the chamber volume. For the preparation of a Ca 2 + -free me dium, Ca 2 + was omitted from the above solution and 0.5 mM ethyleneglycol bis(aminoethylether)tetraacetate was added instead.
Phosphorylation of canine basilar arteries
Transversely cut basilar arteries (2-to 3-mm rings)
were preincubated for I h at 37°C in the Ca 2 + -free me dium containing inorganic 3 2 p (100 f.LCi). Subsequently, PDA was added and the arteries were incubated for a further 15 min. The reaction mixture was heated at 90°C for 5 min and was washed several times with the buffer solution. Tissues were then homogenized in 50 f.Ll sodium dodecyl sulfate using a glass-glass homogenizer. An ali quot of homogenate was subjected to sodium dodecyl sul fate polyacrylamide gel electrophoresis and the gel was subjected to autoradiography as previously described (Ueda and Greengard, 1977) . 
Statistical analysis
Results were analyzed using analysis of variance with a post hoc Dunnett test. p values of <0.05 were taken as significant.
RESULTS
Comparison of contractile activities of PDA, 5-HT,
PGF2"" and endothelin
The mode of canine basilar artery contraction in duced by PDA was compared with that of 5-HT, PGF 2 o.' and endothelin. In the normal medium, PDA induced a slow-developing (usually 8-10 min was required to get the maximal tension after addi tion) and sustained contraction (which lasted at least 1 h after addition) (data not shown), the po tency of which almost corresponded to that of PGF 2 o. (Fig. lA) . The contractile potency of each drug is ex pressed as the percentage of maximal 5-HT contraction (Koide et aI., 1982) , and each value represents the mean ± SD for the num ber of experiments indicated in parentheses. For abbreviations see the text. In the Ca 2 + ·free medium, on the other hand, only PDA caused a significant contraction among the substances examined (Fig. IB) . The ECso thus ob tained was found to be � 10 times higher than that shown in the normal medium, though the maximal tension was unchanged between the two conditions.
Effects of various treatments on
PDA-induced contraction
Pretreatment of the basilar artery with atropine, methysergide, diphenhydramine, phentolamine, in domethacin, or caffeic acid caused no apparent changes in the tension developed by a submaximal concentration of PDA (3 x 10 -7 M) as shown in Table 1 .
Comparison of contracting activities of PDA,
4J3-phorbol, and PbCl2
Neither 413-phorbol, which is structurally similar to PDA but does not activate PKC (Malenka et aI., 1986) , nor PbCI 2 , which activates brain homogenate PKC (Markovac and Goldstein, 1988) , caused sig nificant contractions of the basilar artery (Fig. 2) . Pretreatment of the basilar artery with either staurosporine (Tamaoki et al., 1986) or H-7 (Kawamoto and Hidaka, 1984) , two PKC inhibitors, inhibited the PDA-induced contraction in a dose- 3.15 ± 0.38 (7) 3.24 ± 0.50 (7) 2.85 ± 0.79 (7) 3.00 ± 0.74 (7) 3.00 ± 0.91 (7) 3.35 ± 0.32 (5) 2.84 ± 0.75 (5) All drugs were added 10 min prior to the addition of PDA. The submaximal concentration of PDA to elicit contractions of the canine basilar artery (i.e., 3 x 10-7 M) was used throughout this experiment. Each value represents the mean ± SD for the num ber of experiments indicated in parentheses. (6) PbCI, (5) dependent manner, regardless of whether a normal or a Ca2+ -free medium was employed ( Figs. 3 and  4) . At the highest dose used, complete abolitions were manifested.
Effects of R24571 and quinacrine on
PDA-induced contraction
As shown in Fig. 5 , the effects of R24571 (cal midazolium), a CaM inhibitor (Gietzen et ai. , 1981) , and quinacrine, a PLA 2 inhibitor (Markus and Ball, 1969) , were examined in both the normal and the Ca2+ -free medium.
At the concentration range employed in this study (1 x 10-6-1 X 10-4 M), no significant effects were observed in the case of R24571 except that the compound inhibited PDA-induced contraction at 1
x 10-4 M in the Ca2+ -free medium (Fig. 5B) . Quinacrine, on the other hand, significantly inhib ited PDA-induced contraction in both normal and Ca2+ -free medium at a concentration of 1 x 10-4 M (Fig. 5 ).
Modulation of PDA-induced contraction by cyclic nucleotides
We examined whether cyclic nucleotides affect PDA-induced canine basilar artery contraction. As shown in Fig. 6 , dose-dependent reductions of PDA-induced contractions were manifested by 8bromocyclic GMP, whereas 8-bromocyclic AMP did not exert significant effects at any concentration employed. Staurosporine was added to the incubation mixture 20 min prior to PDA application. Each value represents the mean ± SD for the number of experiments indicated in parentheses.
dium. As shown in Fig. 7 (lanes A and B) , the amount and patterns of protein obtained both from normal and PDA-treated arteries were almost iden tical. Addition of PDA (1 x 10-5 M), however, caused marked increases in the phosphorylation of 27-and 96-kDa and other higher molecular mass proteins (Fig. 7, lanes C and D) . Particularly nota ble was the finding that incorporation of 3 2 p into MLC 20-kDa protein was apparently absent in both normal and PDA-stimulated canine basilar arteries.
DISCUSSION
Involvement of PKC activation in manifestation of
PDA-induced contraction
The present data offer evidence that PDA induced contraction is mediated exclusively by PKC activation within the canine basilar artery.
First, the participation of neurotransmitter sys tems can be precluded because none of neurotrans- mitter antagonists used exerted apparent effects. Second, only PDA induced contraction even in the Ca2 + -free medium among the constrictors exam ined. These data seem of particular importance since in the tracheal muscle, for instance, the DPB induced contraction was shown to be totally depen dent on external Ca2+ (Park and Rasmussen, 1985) , whereas the dependence was only partial in other (8) were 3 x 10-7 and 1 x 10-5 M, respectively. Each value represents the mean ± SD for the number of experiments indicated in parentheses. *p < 0.05; **p < 0.01.
arterial smooth muscles (Forder et aI. , 1985; Glea son and Flaim, 1986; Khalil and van Breemen, 1988) . Thus, the present results are consistent with the notion that some type of PKC can be activated without a prominent increase in the intracellular Ca2+ levels via external Ca2+ influxes (Chiu et aI., 1987; Nishizuka, 1989) . Third, 4p-phorbol, a phor bol without PKC-activating property (Malenka et aI., 1986) , induced only weak contractions of the basilar artery. This indicates that the phorbol struc ture in itself is not involved in the contractile action of PDA. PbCl z , which is an activator of PKC in brain homogenates (Markovac and Goldstein, 1988) , also did not induce contraction. Whether PKC activation induces arterial constriction or not may be due to the difference in the subtypes of PKC within the brain cells (Nishizuka, 1988) . Fourth, two PKC inhibitors, staurosporine and H-7, dose dependently inhibited the PDA-induced contraction not only in the normal, but also in the Ca 2 + -free medium. This result substantiates the idea that PKC activation mediates the PDA contraction, indepen dently of the external Ca2+. In this regard, drug effects on kinases other than PKC should also be taken into account since both staurosporine and H-7 are known to inhibit cyclic nucleotide-depen dent protein kinases at rather high concentrations (Kawamoto and Hidaka, 1984; Tamaoki et aI., 1986) . Last, as exemplified by Nishizuka (1984 Nishizuka ( , 1986 and Ikebe et al. (1985) , the role of PKC needs to be substantiated in terms of the coupling between the PDA-induced protein phosphorylation and the arterial contraction. As described above, the PDA induced contraction did occur in the Ca2+ -free me dium. We took advantage of this fact in an attempt to see phosphorylation states of proteins, which are reflected mainly by PKC but not by Ca2 + /CaM dependent protein kinases. Thus, the phosphoryla tion experiments carried out in the Ca2 + -free me dium revealed two prominent phosphoproteins with apparent molecular masses of 27 and 96 kDa. Of particular interest is the finding that there was no phosphorylation of 20-kDa MLC. In the tracheal smooth muscle, significant MLC phosphorylation was also not reported in the case of DPB (Park and Rasmussen, 1986) . The present results thus provide straightforward evidence that PDA-induced con traction of the canine basilar artery is mediated by phosphorylation of proteins other than MLC.
The differences in protein phosphorylation pat terns between those revealed by the present study and others (Park and Rasmussen, 1986; ChatteIjee and Foster, 1987; Takuwa et aI., 1988 ) may be de pendent on the composition of the contractile pro teins involved.
PDA-induced contraction and the Ca 2 + /CaMlMLCK system
The dose-response curve for PDA obtained in the normal medium shifted to the right when the me- Vol. 11, No.1, 1991 dium was changed to the Caz+ -free medium. Fur thermore, it was shown that R24571, a Ca2+/CaM inhibitor (Gietzen et ai., 1981) , failed to affect PDA induced contraction in the normal medium, while significant inhibitions were obtained at the highest concentration employed in the Caz+ -free medium. These results suggest that the Ca2 + /CaM system does not participate in the PDA-induced contrac tion under normal conditions. The inhibitory effect of R24571 in the Caz+ -free medium may be due partly to the reported inhibitory effect on PKC. However, the possibility that R24571 poorly pene trates cell membranes has also to be considered to interpret the data.
Interactions of cyclic nucleotides with PKC
Tissue levels of cyclic nucleotides are important in the regulation of smooth muscle tone (Edwards et aI., 1985; Waldman and Murad, 1987) . Increments of cyclic AMP level, for instance, relax vascular smooth muscle (Webb and Bhala, 1976; Kroeger et aI., 1977; Stephens and Kroeger, 1981) . A role of cyclic GMP in mediating smooth muscle relaxation is also supported by studies using cyclic GMP ana logues and nitrovasodilators (Greutter et aI., 1981; 19narro et aI., 1981; Edwards et ai., 1984) . In this study, therefore, we carried out experiments along these lines.
An analogue of cyclic GMP, i.e., 8-bromocyclic GMP, preponderantly attenuated the PDA-induced contraction in a dose-related manner, while 8bromocyclic AMP did not. This result clearly shows that the PDA-induced contraction is more suscep tible to the cyclic GMP than to the cyclic AMP system. Further experiments showed that 8-bro mocyclic GMP completely abolishes the phos phorylation of proteins, such as 27-and 96-kDa pro teins, induced by PDA (unpublished data). This result, however, stands in contrast to previous reports that the vascular relaxation induced by cy clic GMP was correlated with the decrease in the phosphorylation of MLC (Draznin et aI., 1983 (Draznin et aI., , 1986 . This discrepancy may be due to the fact that MLC cannot be phosphorylated by treatment with PDA; hence, cyclic GMP may possess the capacity to inhibit the protein phosphorylation mediated by PKC.
Roles of PLAz and arachidonate cascade
Possible involvement of PLA z in the manifesta tion of PDA-induced contraction was examined us ing a PLA z inhibitor, quinacrine (Markus and Ball, 1969) . Quinacrine almost completely inhibited PDA-induced contractions in the normal medium as well as in the Caz+ -free medium. Since brain PLAz does not necessarily require Caz + , whereas Ca2+ is essential for PLC in the brain (Edgar and Freysz, 1982) , it seems unlikely that the possible inhibitory effect of quinacrine on the PLC activity participates in the PDA-induced contraction.
Along these lines, the reaction products of PLA 2 , i. e. , lysophospholipids and arachidonic acid, should be considered as mediators, particularly if we take into account the fact that these two substances are known to stimulate PKC activity (McPhail et al., 1984; Hansson et al., 1986; Farooqui et al., 1988; Oishi et al., 1988; Huang, 1989) . Indeed, we have previously reported that arachidonate possesses strong contractile properties in the canine basilar artery (Koide et al. , 1981 (Koide et al. , , 1982 . Taken together, these data may well implicate the existence of mu tual regulatory mechanisms among PKC, phospho lipids, and PLA 2 • The participation of arachidonate cascade prod ucts can be ruled out since neither indomethacin (a cyclooxygenase inhibitor) nor caffeic acid (a lipoxy genase inhibitor) (Flower, 1974) affected the PDA induced contraction.
CONCLUSIONS
It can be envisaged from this study that, in com parison with that of other vascular smooth muscles, the PDA-induced cerebral artery contraction is rel atively resistant to depletion of external Ca2 +, but virtually inhibited by the cyclic GMP system. On the basis of this novel contractile mechanism, an entirely new field of research will be opened up concerning the cerebral blood flow regulation ill physiological as well as pathological conditions.
